Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
Clinical trial NCT06801730 · RECRUITING
Trial details
- NCT number
- NCT06801730
- Sponsor
- Zhifeng Tian,MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2026-12-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.